After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more

After-hours movers:

Gilead Sciences (NASDAQ: GILD) fell over 3% after WSJ reported The Health and Human Services Department is weighing plans to drastically cut the federal government's funding for domestic HIV prevention.

HealthEquity (NASDAQ: HQY) fell 12% after it reported guidance that was below consensus. HealthEquity sees FY2026 EPS of $3.54-$3.74, versus the consensus of $3.76. HealthEquity sees FY2026 revenue of $1.28-1.305 billion, versus the consensus of $1.309 billion.

CARGO Therapeutics (NASDAQ: CRGX) rose 14% after Board of Directors has made the decision to suspend development efforts of both CRG-023 and CARGO’s allogeneic platform and has appointed Anup Radhakrishnan as interim CEO to lead the Company through a reverse merger or other business combination. Accordingly, CARGO has engaged TD Cowen as the Company’s exclusive strategic financial advisor. In connection with today’s announcement, the Company is also further reducing its workforce by approximately 90%.

StoneCo (NASDAQ: STNE) rose 9% after quarterly EPS topped consensus.

You May Also Be Interested In

• Elliott Wants BP (BP) to Boost Free Cash Flow to $20B by 2027 - Reuters
• Cantor Fitzgerald Assumes Gilead Sciences (GILD) at Overweight
• Grupo Financiero Galicia Sa (GGAL) May 70 calls active as share price up 3.8%